Ignite Creation Date:
2025-12-25 @ 4:17 AM
Ignite Modification Date:
2025-12-26 @ 3:17 AM
Study NCT ID:
NCT01772420
Status:
COMPLETED
Last Update Posted:
2023-07-27
First Post:
2013-01-15
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Phase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia
Sponsor:
Albert Einstein College of Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-10
Start Date Type:
None
Primary Completion Date:
2020-07-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-07-09
Completion Date Type:
ACTUAL
First Submit Date:
2013-01-15
First Submit QC Date:
None
Study First Post Date:
2013-01-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-05-22
Results First Submit QC Date:
None
Results First Post Date:
2023-07-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-24
Last Update Post Date:
2023-07-27
Last Update Post Date Type:
ACTUAL